Do analysts rate LKSP or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lake Superior Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings and valuation, LKSP or BRBI?

BR Biopharma has higher revenue and earnings than Lake Superior Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lake Superior Acquisition N/A N/A N/A N/A N/A BR Biopharma $2.23B 0.07 $31.36M $0.08 175.00

Is LKSP or BRBI more profitable?

Company Net Margins Return on Equity Return on Assets Lake Superior Acquisition N/A N/A N/A BR Biopharma N/A N/A N/A

Do analysts rate BRBI or RILY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 B. Riley Financial 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor BRBI or RILY?

In the previous week, BR Biopharma had 1 more articles in the media than B. Riley Financial. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for B. Riley Financial. B. Riley Financial's average media sentiment score of 0.38 beat BR Biopharma's score of 0.00 indicating that B. Riley Financial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BR Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral B. Riley Financial 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer WTF or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waton Financial 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, WTF or BRBI?

BR Biopharma has higher revenue and earnings than Waton Financial. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waton Financial $11.08M 10.32 -$15.15M N/A N/A BR Biopharma $2.23B 0.07 $31.36M $0.08 175.00

Is WTF or BRBI more profitable?

Company Net Margins Return on Equity Return on Assets Waton Financial N/A N/A N/A BR Biopharma N/A N/A N/A

Do analysts recommend SIEB or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siebert Financial 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to SIEB or BRBI?

In the previous week, Siebert Financial had 1 more articles in the media than BR Biopharma. MarketBeat recorded 3 mentions for Siebert Financial and 2 mentions for BR Biopharma. Siebert Financial's average media sentiment score of 0.52 beat BR Biopharma's score of 0.00 indicating that Siebert Financial is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Siebert Financial 0 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BR Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BRBI or CAPN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cayson Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, BRBI or CAPN?

BR Biopharma has higher revenue and earnings than Cayson Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BR Biopharma $2.23B 0.07 $31.36M $0.08 175.00 Cayson Acquisition N/A N/A N/A N/A N/A

Is BRBI or CAPN more profitable?

Company Net Margins Return on Equity Return on Assets BR Biopharma N/A N/A N/A Cayson Acquisition N/A N/A N/A

Does the media prefer BRBI or CAPN?

In the previous week, BR Biopharma had 1 more articles in the media than Cayson Acquisition. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for Cayson Acquisition. Cayson Acquisition's average media sentiment score of 1.32 beat BR Biopharma's score of 0.00 indicating that Cayson Acquisition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BR Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cayson Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

BR Biopharma (BRBI) Competitors

$13.69 -0.07 (-0.51%)

Closing price 03:53 PM Eastern

Extended Trading

$13.66 -0.04 (-0.26%)

As of 07:30 PM Eastern

Compare

BRBI vs. LKSP, RILY, WTF, SIEB, and CAPN

Should you buy BR Biopharma stock or one of its competitors? BR Biopharma's main competitors and comparable companies include Lake Superior Acquisition (LKSP), B. Riley Financial (RILY), Waton Financial (WTF), Siebert Financial (SIEB), and Cayson Acquisition (CAPN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "investment banking & brokerage" industry.

How does BR Biopharma compare to Lake Superior Acquisition?

Lake Superior Acquisition (NASDAQ:LKSP) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

In the previous week, BR Biopharma had 2 more articles in the media than Lake Superior Acquisition. MarketBeat recorded 2 mentions for BR Biopharma and 0 mentions for Lake Superior Acquisition. Lake Superior Acquisition's average media sentiment score of 0.00 equaled BR Biopharma'saverage media sentiment score.

Company	Overall Sentiment
Lake Superior Acquisition	Neutral
BR Biopharma	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lake Superior Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BR Biopharma has higher revenue and earnings than Lake Superior Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lake Superior Acquisition	N/A	N/A	N/A	N/A	N/A
BR Biopharma	$2.23B	0.07	$31.36M	$0.08	175.00

Company	Net Margins	Return on Equity	Return on Assets
Lake Superior Acquisition	N/A	N/A	N/A
BR Biopharma	N/A	N/A	N/A

Summary

BR Biopharma beats Lake Superior Acquisition on 2 of the 2 factors compared between the two stocks.

How does BR Biopharma compare to B. Riley Financial?

BR Biopharma (NASDAQ:BRBI) and B. Riley Financial (NASDAQ:RILY) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
B. Riley Financial	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, BR Biopharma had 1 more articles in the media than B. Riley Financial. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for B. Riley Financial. B. Riley Financial's average media sentiment score of 0.38 beat BR Biopharma's score of 0.00 indicating that B. Riley Financial is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BR Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
B. Riley Financial	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

BR Biopharma pays an annual dividend of $0.42 per share and has a dividend yield of 3.0%. B. Riley Financial pays an annual dividend of $2.00 per share and has a dividend yield of 41.0%. BR Biopharma pays out 525.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. B. Riley Financial pays out 15.7% of its earnings in the form of a dividend. B. Riley Financial is clearly the better dividend stock, given its higher yield and lower payout ratio.

50.2% of B. Riley Financial shares are owned by institutional investors. 27.8% of B. Riley Financial shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

B. Riley Financial has a net margin of 35.88% compared to BR Biopharma's net margin of 0.00%. B. Riley Financial's return on equity of 39,260.09% beat BR Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BR Biopharma	N/A	N/A	N/A
B. Riley Financial	35.88%	39,260.09%	22.99%

B. Riley Financial has lower revenue, but higher earnings than BR Biopharma. B. Riley Financial is trading at a lower price-to-earnings ratio than BR Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BR Biopharma	$2.23B	0.07	$31.36M	$0.08	175.00
B. Riley Financial	$1.13B	0.17	$307.42M	$12.70	0.38

Summary

B. Riley Financial beats BR Biopharma on 11 of the 14 factors compared between the two stocks.

How does BR Biopharma compare to Waton Financial?

Waton Financial (NASDAQ:WTF) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

BR Biopharma has higher revenue and earnings than Waton Financial.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waton Financial	$11.08M	10.32	-$15.15M	N/A	N/A
BR Biopharma	$2.23B	0.07	$31.36M	$0.08	175.00

Company	Net Margins	Return on Equity	Return on Assets
Waton Financial	N/A	N/A	N/A
BR Biopharma	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waton Financial	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, BR Biopharma had 2 more articles in the media than Waton Financial. MarketBeat recorded 2 mentions for BR Biopharma and 0 mentions for Waton Financial. Waton Financial's average media sentiment score of 0.00 equaled BR Biopharma'saverage media sentiment score.

Company	Overall Sentiment
Waton Financial	Neutral
BR Biopharma	Neutral

Summary

BR Biopharma beats Waton Financial on 3 of the 4 factors compared between the two stocks.

How does BR Biopharma compare to Siebert Financial?

Siebert Financial (NASDAQ:SIEB) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siebert Financial	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BR Biopharma has a net margin of 0.00% compared to Siebert Financial's net margin of -1.07%. BR Biopharma's return on equity of 0.00% beat Siebert Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siebert Financial	-1.07%	-1.25%	-0.15%
BR Biopharma	N/A	N/A	N/A

1.5% of Siebert Financial shares are held by institutional investors. 46.0% of Siebert Financial shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BR Biopharma has higher revenue and earnings than Siebert Financial. Siebert Financial is trading at a lower price-to-earnings ratio than BR Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siebert Financial	$98.92M	0.93	$5.12M	-$0.03	N/A
BR Biopharma	$2.23B	0.07	$31.36M	$0.08	175.00

In the previous week, Siebert Financial had 1 more articles in the media than BR Biopharma. MarketBeat recorded 3 mentions for Siebert Financial and 2 mentions for BR Biopharma. Siebert Financial's average media sentiment score of 0.52 beat BR Biopharma's score of 0.00 indicating that Siebert Financial is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Siebert Financial	0 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BR Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

BR Biopharma beats Siebert Financial on 7 of the 12 factors compared between the two stocks.

How does BR Biopharma compare to Cayson Acquisition?

BR Biopharma (NASDAQ:BRBI) and Cayson Acquisition (NASDAQ:CAPN) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

In the previous week, BR Biopharma had 1 more articles in the media than Cayson Acquisition. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for Cayson Acquisition. Cayson Acquisition's average media sentiment score of 1.32 beat BR Biopharma's score of 0.00 indicating that Cayson Acquisition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BR Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cayson Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cayson Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
BR Biopharma	N/A	N/A	N/A
Cayson Acquisition	N/A	N/A	N/A

BR Biopharma has higher revenue and earnings than Cayson Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BR Biopharma	$2.23B	0.07	$31.36M	$0.08	175.00
Cayson Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

BR Biopharma beats Cayson Acquisition on 2 of the 3 factors compared between the two stocks.

Get BR Biopharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BRBI vs. The Competition

Export

Metric	BR Biopharma	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	$162.50M	$5.16B	$13.43B	$13.39B
Dividend Yield	3.04%	7.58%	6.04%	18.16%
P/E Ratio	N/A	27.75	22.67	20.70
Price / Sales	0.07	1,287.31	518.64	90.24
Price / Cash	4.88	47.69	43.98	53.24
Price / Book	1.15	3.49	2.71	6.33
Net Income	$31.36M	$415.67M	$1.31B	$381.26M
7 Day Performance	23.21%	-0.17%	-0.22%	-0.61%
1 Month Performance	25.30%	-2.77%	-3.18%	-4.84%
1 Year Performance	N/A	11.09%	11.24%	1.12%

BR Biopharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BRBI BR Biopharma	0.3321 of 5 stars	$13.69 -0.5%	N/A	N/A	$162.50M	$2.23B	N/A	188	High Trading Volume
LKSP Lake Superior Acquisition	N/A	$10.25 +0.1%	N/A	N/A	$200.17M	N/A	N/A	2
RILY B. Riley Financial	0.6727 of 5 stars	$4.89 -0.6%	N/A	-17.8%	$196.58M	$1.13B	0.39	1,380	Positive News
WTF Waton Financial	N/A	$2.57 -1.0%	N/A	-61.0%	$123.73M	$11.08M	N/A	51
SIEB Siebert Financial	0.4005 of 5 stars	$2.15 flat	N/A	-23.5%	$88.37M	$98.92M	N/A	166

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BRBI) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BR Biopharma (BRBI) Competitors

BRBI vs. LKSP, RILY, WTF, SIEB, and CAPN

How does BR Biopharma compare to Lake Superior Acquisition?

Summary

How does BR Biopharma compare to B. Riley Financial?

Summary

How does BR Biopharma compare to Waton Financial?

Summary

How does BR Biopharma compare to Siebert Financial?

Summary

How does BR Biopharma compare to Cayson Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BRBI vs. The Competition

BR Biopharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BR Biopharma (BRBI) Competitors

BRBI vs. LKSP, RILY, WTF, SIEB, and CAPN

How does BR Biopharma compare to Lake Superior Acquisition?

Does the media refer more to LKSP or BRBI?

Do analysts rate LKSP or BRBI?

Which has preferable earnings and valuation, LKSP or BRBI?

Is LKSP or BRBI more profitable?

Summary

How does BR Biopharma compare to B. Riley Financial?

Do analysts rate BRBI or RILY?

Does the media favor BRBI or RILY?

Is BRBI or RILY a better dividend stock?

Do institutionals and insiders believe in BRBI or RILY?

Is BRBI or RILY more profitable?

Which has preferable earnings and valuation, BRBI or RILY?

Summary

How does BR Biopharma compare to Waton Financial?

Which has preferable earnings & valuation, WTF or BRBI?

Is WTF or BRBI more profitable?

Do analysts prefer WTF or BRBI?

Does the media prefer WTF or BRBI?

Summary

How does BR Biopharma compare to Siebert Financial?

Do analysts recommend SIEB or BRBI?

Is SIEB or BRBI more profitable?

Do institutionals and insiders believe in SIEB or BRBI?

Which has better earnings and valuation, SIEB or BRBI?

Does the media refer more to SIEB or BRBI?

Summary

How does BR Biopharma compare to Cayson Acquisition?

Does the media prefer BRBI or CAPN?

Do analysts prefer BRBI or CAPN?

Is BRBI or CAPN more profitable?

Which has stronger earnings & valuation, BRBI or CAPN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BRBI vs. The Competition

BR Biopharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools